Abstract-This article discusses the acquisition and processing of multimodal physiological data from patients with epilepsy in epilepsy monitoring units for the discovery of risk factors for sudden expected death in epilepsy that can be combined through integrative analysis for biomarker discovery.
I. INTRODUCTION
Sudden unexpected death in epilepsy (SUDEP) is the most common form of epilepsy related death with 1-1.2 incidence per thousand per year in people with epilepsy [1] . These incidence rates have remained unchanged, since SUDEP was first recognized in 1910, in spite of significant advances in treatment and management of epilepsy over the same time period [2] . Case-control risk assessment studies indicate a typical SUDEP phenotype is that of a patient with early (<16 years of age) onset, longstanding (>16 years) epilepsy with frequent generalized tonic-clonic seizures (GTCS) that are difficult to control. In addition, it is noted that SUDEP most often occurs in the nocturnal hours or in relation to sleep [3] . Although precise mechanisms underlying SUDEP have yet to be identified, recent research implicated that cardio-respiratory dysfunction is a potential biomarker [6] . However, in spite of identification and analysis of these mechanisms and risk factors of SUDEP, it is still not possible to predict individual risk. It has been suggested that seizures and SUDEP might represent complex systems, each with heterogeneous, multifactor pathophysiology, in which multiple, simple processes interact in unpredictable and potentially catastrophic ways [7] . However, the complexity of the etiology highlights the fact that the only way an intervention strategy can be finally formulated for SUDEP is through the discovery of robust and reliable physiological signal-based biomarkers that requires multimodal data acquisition along with the appropriate algorithms for univariate and multivariate data analysis (feature extraction and feature reduction) and integrative analysis.
II. MULTIMODAL DATA ACQUISITION AND ANALYSIS

A. Multimodal Data Acquisition and Conversion
In the epilepsy monitoring unit (EMU), physiological signals are measured using a collection of different sensors (e.g., EEG or ECG electrode) or different devices [e.g., pulse oximeter or noninvasive arterial blood pressure (BP)]. Some physiological information, such as respiratory data can be monitored by different types of sensors, e.g., respiratory inductance plethysmography, impedance pneumography, nasal pressure transducer, etc. These monitoring devices are connected to the data acquisition systems for real-time monitoring. The combination of monitoring devices and acquisition systems can be varying across different medical centers.
In the Center for SUDEP Research (CSR) at Case Western Reserve University, the data comes from different medical centers. The acquisition systems from these centers include Nihon Kohden, Nicolet, and Micromed. In addition, real-time recording from different centers can contain different signals depending on availability and the clinical protocol of the corresponding center. These acquisition systems generally have proprietary data formats and often do not provide a reliable means of converting data to an open data format, such as the EDF [8] , [9] . Direct communication with the vendors of each acquisition system is critical to obtain the information and/or tools that are necessary to properly transform all data being acquired into a selected standard data format for subsequent review and cohort analysis.
The variations in clinical data records due to different clinical protocol across centers can manifest in a number of ways that can affect the interpretation of the annotations. For example, the omission of clinical information because it is not part of the clinical workflow at an individual site can lead to misinterpretation of important annotations in the recorded data by analysts who do not have the necessary clinical expertise.
Conversion of multimodal clinical data for large-scale analysis requires clinical review, unifying the clinical terminology so that the data can be effectively searched based on a standard set of keywords, as well as conversion to a standardized data format. Clinical review and unifying the terminology are time intensive by their very nature while the computational burden in data conversion is due to sheer volume of data from the EMU, e.g., approximately 1-24 GBytes/day per patient. Implementing an appropriate workflow that allows simultaneous clinical data review and data conversion to EDF, along with complete and accurate clinical annotations while ensuring data from different centers, is converted accurately and reliably is essential [10] . EEG pattern during PGES with artifact that is difficult to identify for nonexpert researchers, making it difficult to distinguish these two EEG patterns that are from different stages of recovery from the same patient after PGES.
B. Multimodal Data Analysis
The human body is an extremely complex system that consists of multiple subsystems that are controlled and/or regulated by the nervous system. These subsystems can be either tightly or loosely coupled depending on their functionality and their operating state. Thus, health not only depends on the condition of individual subsystems but also on their dynamic interactions. Although the exact cause of SUDEP is not yet known, it is undeniable that there must be one or more irregularities in physiological functions of the patient prior to SUDEP. The main focus research in the potential cause(s) of SUDEP consists of detailed studies that include at least three major systems: the nervous system, the cardiac systems, and the respiratory system. However, the changes in any of the interactions among these systems during various stages, such as preictal (prior to a seizure), ictal (during a seizure), postictal (immediately after a seizure), and interictal (between seizures), have not been well studied.
Postictal generalized EEG suppression (PGES) is a pathophysiological response observed in the brain of a patient with epilepsy after the ictal period and during the postictal period of a GTCS. It has been characterized as a period of absence of baseline electrical activity in the brain with measured EEG peak-to-peak amplitude less than 10 µV on the scalp. Prolonged PGES (>50 s) has been identified as a potential predictor of SUDEP [22] in patients with epilepsy. While there exist algorithms ranging from fuzzy inference systems [23] for seizure detection to statistical learning models [25] for pattern recognition, these methods have not been applied to the detection of PGES other than in [26] .
The standard montage for acquiring scalp EEG in the EMU follows the 10-20 protocol for electrode placement. Each channel of EEG data is acquired at a sampling rate between 250 and 1000 Hz, and up to 10 000 Hz if recordings from intracranial electrodes are included, with appropriate high pass and low pass filters to eliminate dc and to prevent aliasing in the acquired signals. Analyzing PGES requires simultaneously processing all the EEG channels. Although the amplitude criterion is used to define EEG suppression, because of motion and physiological artifact that contaminate the EEG signals during acquisition (see Fig. 1 ), the amplitude criterion alone is insufficient in accurately and reliably determining the start and end times of EEG suppression periods. To address this problem, we have developed an algorithm for detection of PGES from EEG records curated consistently to be able to compare PGES annotations directly across different acquisition systems in EDF format. While clinical annotators reviewing the patient EEG data also had access to video recording to assist in distinguishing genuine periods of EEG suppression in the presence of artifacts, the algorithm was developed to produce its analysis from scalp EEG signals alone.
Because of the difficulty in reliably identifying and scoring PGES, the design procedure for the algorithm included feature extraction, feature reduction, and then classification. For the classification step, we used a supervised training method that used clinical data from the EMU that was reviewed and annotated on PGES events. Ocular, muscle, and motion artifacts, which are not clinically annotated, places an additional burden on the algorithm to be able to distinguish between artifact and genuine physiological electrical activity in order to accurately identify the end of PGES. The training dataset included example records with and without PGES.
We apply the Short-Time-Fourier-Transform (STFT) with a rectangular sliding window to the EEG electrode voltages from the 10-20 scalp EEG montage. The STFT representation is binned into physiologically meaningful frequency bands, such as the Delta, Theta, Alpha, and Gamma bands corresponding to 1-4, 4-7, 7-12, and 30-70 Hz, respectively, for our application. In the Gamma range, we ignore European and American electricity frequencies of 50 and 60 Hz, respectively. A classifier model determines where suppression begins and ends postictal record on these covariates at each epoch in the STFT covariates determines where suppression begins and ends postictal record. The model is fit to the annotation times, given the covariate Delta, Theta, Alpha, and Gamma STFT data. From the trained model, we are able to make predictions of PGES duration, beginning and end times for postictal periods from unscored seizure records; for additional details, see [26] .
Heart rate variability (HRV), quantifies the variation in the heart beat-to-beat interval measured from ECG signals and is a physiological phenomenon that has been extensively investigated in Cardiac system. Increased/decreased HRV has been shown to be associated with various outcomes/conditions, such as congestive heart failure, diabetic neuropathy, depression, postcardiac transplant, susceptibility to sudden infant death syndrome (SIDS), and poor survival in premature babies [21] .
Clear identification of normal R-waves, with no measurement artifact and arrhythmic beats, is required for HRV analysis [15] . Because HRV is highly sensitive to artifact and small errors (2%), the results can be changed significantly in long-term clinical recordings. Normally, experienced clinical personnel carefully review each ECG signal to identify HRV segments that only include sinus beats, and this review is a very time-consuming process. We have developed an automatic processing tool to calculate the HRV measures from multivariate ECG signals. The tool automatically identifies each R-wave, i.e., measurement artifacts, plots the distribution (histogram) of R-R intervals and estimates the minimum and maximum permissible R-R interval based on R-R distribution to propose HRV segments that are free of artifacts. Generally, the short and long R-R intervals are associated with irregular beats and errors in detected beats/artifacts. The minimum and maximum R-R interval has been considered as 2.5 times the standard deviation (SD) of the R-R interval distribution. Finally, the tool automatically calculates the results of the HRV analysis with respect to the identified artifact free HRV segments.
The results from our HRV analysis include both conventional and novel measures that are based on either the time or frequency domains. Conventional HRV uses statistical measures such as mean, SD, and root mean square (RMS) of R-R intervals (referred to as NN-normalto-normal) to quantify the variability of the underlying sinus rhythm. Statistical measures can depend on the length (window) of the data being analyzed, so it is common to use 5-min epochs of artifact free ECG for short-term variability analysis and 24-h recordings for longer term studies. Comparisons of HRV statistical measures should be done only for data of similar length. Typical statistical HRV quantities include MNN (mean of the NN intervals); SDNN (the mean of the 5-min SD of NN intervals calculated over 24 h), SDANN (standard deviation of the average NN intervals calculated over 5-min periods), RMSSD (square root of the mean squared differences of successive NN intervals), NN50 (number of interval differences of successive NN intervals greater than 50 ms), and pNN50 (proportion derived by dividing NN50 by the total number of NN intervals); see [15] for more details. Other time series measures, such as those derived from the Poincaré plot [14] , provide useful information obtained from the R-R interval data by presenting and quantifying the variations in the ECG time series over different periods of time; both short-term and long-term variability measures can be derived from the analysis, which is complementary to the standard time series variability measures discussed in [15] .
Standard spectral analysis for equally spaced (uniformly sampled) time series data is based on the Fast Fourier Transform (FFT). However, the R-R interval data is not uniformly sampled because the time between two consecutive heartbeats is not constant. Therefore, a technique for calculating the spectral representation of unevenly sampled data has been used [16] for spectral analysis of the R-R time series. Using this approach, the normalized low frequency (LF) power (from 0.04 to 0.15 Hz) and the normalized high frequency (HF) power (from 0.15 to 0.4 HZ) have been calculated.
For nonlinear analysis, detrended fluctuation analysis (DFA) has been considered. DFA is a technique introduced by Peng et al. in 1995 to quantify the long-range correlation behavior in nonstationary physiological time series data [20] . To apply DFA to ECG time series data, long-range correlations between interbeat intervals separated by several beats are detected by investigating the scaling behavior of heartbeat fluctuations on different time scales disregarding trends and nonstationary characteristics in the data. In 2003, Penzel had defined small and large time scales to determine if there are short-term and long-term correlations in the heartbeat time series signal [19] . DFA scaling parameters Alpha1 and Alpha2 are estimated from the time series data, where Alpha1 corresponds to time scales between 10 and 40 heartbeats, characterizing short-term correlation behavior, and Alpha2 corresponds to time scales between 70 and 300 heartbeats to observe long-term correlation behavior. In our analysis, we have used the same approach to estimate Alpha1 and Alpha2.
The HRV tool has been used to process data from 281 EMU patients from University Hospitals. The average recoding time for each subject is between four and five days and four ECG leads have been recorded during monitoring. The tool automatically detects each ECG channel, processes each channel to detect the R-waves along with artifacts, and selects a channel with minimum artifact for the HRV calculations. Then, once all 5-min ECG segments with no artifacts have been detected and HRV measures for each segment have been calculated, the result of analysis has been stored for statistical evaluation of HRV measures.
Baroreflex is a cardiovascular feedback control mechanism responsible for the maintenance of circulatory homeostasis. It reflects autonomic control mediated by medullary autonomic neural circuits [11] . Baroreflex sensitivity (BRS) is a multimodal measure that is used to assess neural cardiovascular regulation in both normal and disease states. Existing research indicates that immediate postictal hypotension [12] in GTCS; peri-ictal hypotension seemingly associated with impaired BRS may contribute to SUDEP due to delay in BP compensatory mechanisms.
Algorithms for BRS assessment can be categorized into two main approaches [13] : time-domain and frequency-domain approaches. Both approaches require systolic blood pressure (BPsys) from the BP signal and R-R from the ECG signal. In the time-domain, spontaneous BRS assesses BRS by identifying spontaneous sequences consisting of three or more consecutive beats in which BPSys is progressively rising when the R-R interval is progressively lengthened; or BPSys is progressively decreasing when the R-R interval is progressively shortened. This method requires more data (usually around 30 min) so that there is a sufficient number of BPsys increasing and decreasing sequences to compute statistically meaningful slopes between BPsys and R-R interval (or heart period (HP), which is the inverse of the R-R interval) of the selected BRS segments. For the frequency-domain approach, the time series data was converted to the frequency domain using the Lomb-Scargle periodogram, and the spectral BRS was calculated as the average of the magnitude ratio (transfer function) between oscillations of BPsys (considered as the input) and heart period in the two frequency ranges, e.g., 0.04-0.15 Hz for LF and 0.15-0.4 Hz for HF. Spectral BRS requires sufficient coherence (>0.2) between BPsys and the R-R interval as a conventional criterion to guarantee reliable estimates of the magnitude ratio. In general, epochs between 2-5 min are used for spectral processing.
For reliable computation, both the BP and ECG signals need to have sufficiently high signal-to-noise ratio (SNR) for extracting BPsys and the R-R interval and the BP and ECG timer series data. In the EMU, ECG signals are observed from more than one location. Thus, reliable heart beat detection can be done from multiple ECG channels in most situations, and the data can be fused to provide very reliable and robust R-wave detection. In contrast, real-time BP measurements are extremely challenging in the EMU because clinicians want to observe seizure manifestation to determine further treatment plan for patients with epilepsy in the EMU, and therefore, patients are taken off their antiepileptic medications when they arrive in the Unit. For this reason, intra-arterial BP, which provides the most reliable measurement, cannot be used in EMU. Only few medical units employ noninvasive BP real-time monitoring with much lower SNR compared to the invasive measurement (see Fig. 2 ). This increases the challenge for reliable assessment of BRS for both the time-domain and frequency-domain methods.
C. Multimodal Data Analysis
Large amounts of real-time recordings from multiple patients with epilepsy are required for discovering biomarkers for SUDEP. The CSR at CWRU has been collecting multimodal data for more than three years from five different centers. The analysis requires an extensive computational effort to convert the recorded data to a standardized data format, such as EDF, analyze the EEG, BP (when available), respiratory (thoracic and abdominal belts), and ECG data to extract features from the raw time-series data and then combine the data in a meaningful way across a diverse group of patients with epilepsy. Physiological data is combined with demographic data (age, gender, etc.) and clinical data (e.g., seizure type, etiology, and frequency of occurrence) to define the complete dataset for analysis. Our process of SUDEP biomarker discovery is based on the working hypothesis that understand the dynamics of autoregulation during the preictal and postictal periods is the key. Our analysis approach is to fuse the diverse elements of the dataset to discover the relationships between these data and SUDEP by combining EEG suppression parameters (e.g., PGES duration, dynamic characteristics of suppression during Intermittent and Continuous Slow EEG, recovery time to Rhythmic EEG), BP parameters (BPsys during preictal and postictal periods, recovery time to interictal BP), ECG parameters from HRV, and BRS. Data-driven approach is based on the discovery of a network model; nodes are physiological variables, edges define connectivity between the nodes, and temporal patterns of transitions in network connectivity are potential biomarkers (see Fig. 3 ).
III. CONCLUSION AND FUTURE WORK
We have assembled a multimodal dataset from a diverse population of patients with epilepsy, have developed feature extraction and reduction techniques for the time-series data, and have combined these features with other patient related data using integrative analysis approaches to better understanding SUDEP risk factors.
